AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2021
Jan 27, 2021
31982_dirs_2021-01-27_361ac502-230e-4c4c-8808-c76af5592f31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-01-25
Reporting Person: Trizzino John (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-25 | Common Stock | S | 73 | $128.6037 | Disposed | 287 | Direct |
Footnotes
F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The Reporting Person is amending the Form 4 originally filed to report this sale solely for the purpose of correcting the column 3 code. The correct code is "S".